Not Signed In - NeoRecormon Gains European Approval For Convenient Once Weekly Treatment Of Anaemia In Patients With Solid Cancers
Mon, 15 Jan 2007 08:00 AM EST
... Roche announced today that it has received European marketing approval for a simple and convenient once weekly subcutaneous injection of NeoRecormon (epoetin beta) 30,000 IU for the treatment of anaemia in patients with solid cancers receiving chemotherapy. [click link for full article] ...
Related Topics
- MMA
- Morbidity & Mortality Weekly Report
- Vaccine Testing & Approval
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Atherosclerosis
- Smoking Cessation and Continued Risk in Cancer Patients
- Black Alder
- Unusual Cancers of Childhood
- Unusual Childhood Cancers
- Treatment
- X-linked sideroblastic anemia
- Treatments
- European Goldenrod
- Cancers
- Tarceva
- AIDS-Related Cancers
- Breast Lumps & Other Breast Conditions
- Fetal Development
- Childhood Cancers
email this page
print this page
bookmark this page
feedback on this page
